Novo expands EU footprint with $200m Novavax plant
The 150,000 square-foot Bohumil, Czech Republic site currently manufactures recombinant proteins used in vaccines. Novo has acquired the facility along with all its support infrastructure and an existing workforce of 150 employees. According to the …